aibioIVF INVO Fertility, Inc.
INVO Fertility (IVF) news
INVO Fertility, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker IVF, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest INVO Fertility news
We have not published a story on INVO Fertility yet. When there is news, it will appear here.
INVO Fertility annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $6.8 million | $6.5 million |
| Research and development | $4,880 | |
| Net income (loss) | -$23.3 million | -$9.3 million |
| Cash from operations | -$7.0 million | -$3.0 million |
Questions about INVO Fertility
What is the ticker symbol of INVO Fertility?
INVO Fertility, Inc. trades under the ticker IVF on NASDAQ.
Where is INVO Fertility listed?
INVO Fertility, Inc. is listed on NASDAQ.
Which country or territory is INVO Fertility listed under?
Our directory records INVO Fertility, Inc. under United States.
Does aibio.space cover INVO Fertility?
aibio.space lists INVO Fertility, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
What was INVO Fertility's revenue last year?
$6.8 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.
Is INVO Fertility profitable?
INVO Fertility, Inc. reported a net loss of $23.3 million for the fiscal year ended Dec 31, 2025, and used $7.0 million of cash in operations, per its annual report to the SEC.
How much cash does INVO Fertility have?
$2.0 million in cash at Jun 30, 2022, per its 10-Q.
Investor discussion: INVO Fertility
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Financings
Reported an unregistered sale of its securities. SEC Form 8-K (Items 1.01,3.02,5.03,5.07,9.01). Source
- Legal
Said earlier financial statements should no longer be relied on. SEC Form 8-K (Items 4.02,9.01). Source
- Distress
Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. Source
- Listings
Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01,7.01,9.01). Source
Stock chart
Listing details
- Company
- INVO Fertility, Inc.
- Ticker
- IVF
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction